Johnson David Michael (CIK 0001808098)

Latest company ownership

Shares held
289,672
Last filed at
Jun 24, 2024
Confidence Score
51.8
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
250,421
Last filed at
Jun 18, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 16, 2025 May 20, 2025 Aura Biosciences, Inc. Director Buy 87.5 +20,000 4.59% ✗ $98K
Nov 10, 2023 Nov 13, 2023 Zentalis Pharmaceuticals, Inc. Director Buy 95.0 +17,000 13.34% ✗ $167.9K
Nov 7, 2023 Nov 9, 2023 Aura Biosciences, Inc. Director Buy 100.0 +199,601 56.11% ✗ $1.4M
Oct 3, 2023 Oct 5, 2023 Aura Biosciences, Inc. Director Buy 90.0 +20,066 9.76% ✗ $168.2K
Jan 5, 2023 Jan 9, 2023 Aura Biosciences, Inc. Director Buy 86.3 +2,000 5.88% ✗ $20.8K
Dec 28, 2022 Dec 30, 2022 Aura Biosciences, Inc. Director Buy 91.3 +4,000 13.33% ✗ $39K
Dec 1, 2022 Dec 15, 2022 Aura Biosciences, Inc. Director Buy 95.0 +10,000 50.00% ✗ $123.7K
Jun 10, 2022 Jun 14, 2022 Aura Biosciences, Inc. Director Buy 97.5 +50,000 100.00% ✗ $716.3K
Oct 4, 2021 Oct 4, 2021 Zentalis Pharmaceuticals, Inc. Director Sell 22.5 -12,896 -13.74% ✓ $855.6K
Apr 5, 2021 Apr 5, 2021 Zentalis Pharmaceuticals, Inc. Director Sell 22.5 -12,897 -12.67% ✓ $561K
Apr 7, 2020 Dec 3, 2020 Zentalis Pharmaceuticals, Inc. Director Sell 26.3 -8,896 -8.04% ✓ $590.7K